Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
S. Sharman Moser, L. Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, G. Chodick, N. Siegelmann-Danieli
{"title":"Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting","authors":"S. Sharman Moser, L. Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, G. Chodick, N. Siegelmann-Danieli","doi":"10.2147/bctt.s439158","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505521,"journal":{"name":"Breast Cancer: Targets and Therapy","volume":"9 24","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer: Targets and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/bctt.s439158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
